Abemaciclib,Anastrozole,Letrozole
Eli Lilly,Novartis
['mbc', 'abema', 'bcsm', 'abemaciclib']
live from #esmo2022: improvement in overall survival with ai+abemaciclib (vs ai+placebo) as 1st line therapy for hr+ mbc, mos: 67.1m vs 54.5m, hr: 0.75 (interim analysis from monarch-03 trial). final os results expected next year. #bcsm 
Medical Oncologist, MGH, Harvard Medical School. Interested in cool science, technology, patient stories, and therapies against cancer.